Use of beta-2 agonists and risk of hip fracture

Παρόμοια τεκμήρια

• Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
  ανά: de Vries, F, κ.ά.
  Έκδοση: (2007)
• Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
  ανά: de Vries, F, κ.ά.
  Έκδοση: (2007)
• Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
  ανά: de Vries, F, κ.ά.
  Έκδοση: (2007)
• Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
  ανά: De Vries, F, κ.ά.
  Έκδοση: (2006)
• Use of protonpump inhibitors and risk of hip fracture
  ανά: Lalmohamed, A, κ.ά.
  Έκδοση: (2009)